CRH (CRH) Rises Higher Than Market: Key Facts

CRH (CRH) recently gained 1.37% to $95.54, outperforming the S&P 500 on the day, though its 4.8% monthly gain trailed the broader Construction sector. The building materials firm is set to report earnings on August 6, 2025, with consensus estimates projecting a 6.99% revenue increase to $10.33 billion but a minor 0.54% decline in quarterly EPS to $1.84 year-over-year, following a recent 2.51% downward revision in the EPS forecast. Despite this, full-year estimates anticipate robust growth, with EPS up 4.27% to $5.62 and revenue up 6.81% to $38 billion. CRH holds a Zacks Rank #3 (Hold) and appears undervalued relative to its industry, trading at a Forward P/E of 16.78 and PEG of 1.47 compared to industry averages of 17.9 and 1.9, respectively.

Analysis

CRH plc (CRH) presents a mixed financial picture, characterized by recent stock outperformance against a backdrop of conflicting forward-looking indicators. The stock's 1.37% daily gain surpassed the S&P 500, but its 4.8% monthly return lagged both its sector (6.08%) and the broader market. Analyst consensus for the upcoming quarter ending August 2025 projects robust revenue growth of 6.99% to $10.33 billion, yet anticipates a slight year-over-year earnings decline, with EPS expected to fall 0.54% to $1.84. This near-term earnings pressure is underscored by a 2.51% downward revision in the consensus EPS projection over the past 30 days, a key bearish signal. In contrast, the full-year outlook remains positive, with estimates calling for 4.27% EPS growth and 6.81% revenue growth. On a valuation basis, CRH appears attractive, trading at a Forward P/E of 16.78 and a PEG ratio of 1.47, both of which represent discounts to its industry averages of 17.9 and 1.9, respectively. This combination of a favorable valuation and strong industry ranking (top 40%) is tempered by the negative short-term estimate revisions, justifying its current Zacks Rank of #3 (Hold).

Key Decisions for Investors

• Given the conflicting signals of strong full-year guidance versus negative near-term EPS revisions, a neutral or 'Hold' position appears warranted until the upcoming earnings release on August 6, 2025 provides more clarity.
• Value-oriented investors may find the current valuation compelling, as CRH trades at a discount to its industry on both a Forward P/E and PEG ratio basis, suggesting a potential entry point for those with a longer-term investment horizon.
• Investors should closely monitor for further analyst estimate revisions, as the recent 2.51% downward adjustment in consensus EPS is a primary risk factor that could signal deteriorating short-term business trends or margin pressures.